Anna Bigas

Josep Carreras Leukaemia Research Institute

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Giovanni Tonon

Unit Head

Ospedale San Raffaele

ITALY

View details

Alessandra Giorgetti

Universitat Autònoma de Barcelona Facultat de Medicina

SPAIN

View details

Bernhard Payer

University of Montreal

CANADA

View details

Jose Regueiro

Vice-Dean for Research and PhD Studies

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Mercedes Dosil

Associate Professor

Universidad de Salamanca Facultad de Medicina

SPAIN

View details

Teresa Lobo Jarne

Institut d'Investigacions Biomèdiques August Pi i Sunyer

SPAIN

View details

Javier Robles-Valero

Profesor Asociado

Universidad de Salamanca

SPAIN

View details

Csaba Bödör

Semmelweis University

HUNGARY

View details

Moises Mallo

Principal Investigator and Chief Scientific Officer

Gulbenkian Institute for Molecular Medicine

PORTUGAL

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Bigas

Research Interests

Explore related searches

Contact this professor

Articles (14)

UNCAN.eu: Toward a European Federated Cancer Research Data Hub

The interferon γ pathway enhances pluripotency and X-chromosome reactivation in iPSC reprogramming

IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development

Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate

β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.

beta-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia

Characterization of the spectrum of trivalent <i>VAV1</i> ‐mutation‐driven tumours using a gene‐edited mouse model

Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development

Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development

IkappaBalpha controls dormancy induction in Hematopoietic stem cell development via retinoic acid

GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects

GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects

Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials.

Sézary syndrome patient-derived models allow drug selection for personalized therapy.

Collaborators (9)

Giovanni Tonon

Alessandra Giorgetti

Bernhard Payer

Jose Regueiro

Mercedes Dosil

Teresa Lobo Jarne

Javier Robles-Valero

Csaba Bödör

Moises Mallo

Make your next move.